Bremelanotide acetate - Generic Drug Details
✉ Email this page to a colleague
What are the generic drug sources for bremelanotide acetate and what is the scope of freedom to operate?
Bremelanotide acetate
is the generic ingredient in one branded drug marketed by Palatin Technologies and is included in one NDA. There are four patents protecting this compound. Additional information is available in the individual branded drug profile pages.Bremelanotide acetate has seventy-nine patent family members in twenty-five countries.
One supplier is listed for this compound.
Summary for bremelanotide acetate
International Patents: | 79 |
US Patents: | 4 |
Tradenames: | 1 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 1 |
DailyMed Link: | bremelanotide acetate at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for bremelanotide acetate
US Patents and Regulatory Information for bremelanotide acetate
Expired US Patents for bremelanotide acetate
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Palatin Technologies | VYLEESI (AUTOINJECTOR) | bremelanotide acetate | SOLUTION;SUBCUTANEOUS | 210557-001 | Jun 21, 2019 | See Plans and Pricing | See Plans and Pricing |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for bremelanotide acetate
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Israel | 159797 | See Plans and Pricing | |
Australia | 2005269831 | See Plans and Pricing | |
Canada | 2573142 | See Plans and Pricing | |
Australia | 2002322466 | See Plans and Pricing | |
Spain | 2235921 | See Plans and Pricing | |
Mexico | PA06013814 | TERAPIA DE AGENTES MULTIPLES PARA LA DISFUNCION SEXUAL. (MULTIPLE AGENT THERAPY FOR SEXUAL DYSFUNCTION.) | See Plans and Pricing |
Japan | 2008500369 | See Plans and Pricing | |
>Country | >Patent Number | >Title | >Estimated Expiration |